4 results about "Beta-Carotene" patented technology

The invention discloses bubble candies capable of supporting vision health and a preparation method of the bubble candies, and belongs to the technical field of food processing. The bubble candy comprises vitamin C, sodium ascorbate, lutein ester, zeaxanthin, astaxanthin, anthocyanin, beta carotene, semen cassiae, chrysanthemum, DL-malic acid, citric acid, sodium bicarbonate, sorbitol, xylitol, sucralose, stevioside, aspartame, passion fruit powder essence, magnesium stearate, sunset yellow aluminum lake, allura red aluminum lake and lemon yellow aluminum lake. The preparation method comprises the following steps: (1) weighing; (2) mixing; (3) tabletting; and (4) packaging. Starting from the goal of protecting eyesight health, vitamins, minerals and functional plant extract raw materials are taken as main materials, a carrier sorbitol with good compressibility, citric acid capable of improving bubble feeling, sodium bicarbonate and the like are taken as auxiliary materials, and according to a high-quality production process, the product dosage form is designed into the bubble tablet candy, so that the bubble tablet candy has better stability, and is suitable for popularization and application. The carrying is convenient.

USE OF A COSMETIC COMPOSITION RICH IN FATTY ACIDS, BETA CAROTENE AND VITAMIN E FOR SKIN PROTECTION AGAINST OXIDATIVE STRESS The present invention relates to the use of a cosmetic composition comprising, by weight relative to the total weight of the composition, between 4 and 6% apricot kernel oil, between 3 and 8% carrot root extract, between 8 and 12% jojoba oil, between 25 and 35% carrot aerial parts hydrosol, between 8 and 12% orange blossom floral water, between 0.1 and 0.5% orange essential oil, between 0.1 and 0.5% wheat germ oil, between 0.1 and 0.5% sea buckthorn berry extract, and between 15 and 35% water, to protect the skin against oxidative stress and preventing and / or delaying the signs of aging induced by oxidative stress. [Fig.1]

13-cis retinoic acid (13-cis) is a potent teratogen that crosses the placenta and exists in equilibrium with 13-trans retinoic acid (13-trans). Compared to 13-trans, 13-cis is preferentially concentrated in the cell nucleus where it is isomerized to teratogenic 13-trans. In pregnant mothers the plasma 13-cis concentration is highest in the first 8-12 weeks of pregnancy. Neurocognitive impairment even in the absence of any physical defects has been reported to be 30%-60% of children exposed to Isotretinoin (13-cis) during the prenatal period. Genetic variability of CYP26A1 and / or CYP26B1 may be passed onto the fetus and is probably associated with increased maternal and fetal retinoid concentrations. Beta carotene crosses the placenta but may be metabolized and / or stored by the fetus differently than in adults. Measuring maternal retinoids and CYP26A1 and CYP26B1 activities may provide insight into the steep rise in neurodevelopment disorders not explained by improvement in diagnosis.

The present invention is drawn towards a composition comprising Artepillin C, naringenin, a carotenoid, and a pharmaceutically acceptable carrier, wherein the carotenoid is selected from the group consisting of beta-carotene, lycopene, or lutein, and methods of using the composition for local fat reduction and / or treating a subject afflicted with a metabolic disorder.